Home > Insider Trading > Filing (0001209191-17-031418)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1625101	Pulse Biosciences Inc.	PLSE	Surgical & Medical Instruments & Apparatus (3841)	465696597

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1625594	J. Robert Greenberg	849 Mitten Road, Suite 104 Burlingame CA 94010		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-05-10	25,000	$2.67	25,000	No	4	M	Direct
Common Stock	Disposition	2017-05-10	22,180	$21.03	2,820	No	4	S	Direct
Common Stock	Disposition	2017-05-10	2,820	$21.87	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2017-05-10	25,000	$0.00	25,000	$2.67

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
50,655		2020-06-01	No	4	M	Direct

Footnotes

This is the weighted average purchase price of the shares, which ranged from $20.62 to $21.57 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
This is the weighted average purchase price of the shares, which ranged from $21.77 to $21.96 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
The shares subject to the option will vest in equal quarterly installments over a three year period that commenced on June 1, 2015 and will end on Marcn 1, 2018, subject to the Reporting Person's continued service through each vesting date.